ArticleOncology reports2017

MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.

Xin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.